Oxycodone Hydrochloride Wockhardt Uk

Active Ingredient:: Oxycodone Hydrochloride
Origin:: EU

Oxycodone Hydrochloride Wockhardt Uk (Oxycodone Hydrochloride)

International sale not permitted. Listed for the domestic market and B2B only.

Oxycodone Hydrochloride, the active ingredient in Oxycodone Hydrochloride Wockhardt Uk, is an opioid analgesic presented as an oral tablet for oral use. It is prescribed to manage moderate to severe pain in adult patients when other analgesics are insufficient.

GNH India supplies Oxycodone Hydrochloride Wockhardt Uk as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Wockhardt Uk Ltd

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Oxycodone Hydrochloride is an opioid analgesic used in the management of moderate to severe pain.

Acute postoperative pain: provides rapid relief after surgical procedures.
Cancer‑related pain: controls persistent pain associated with malignant disease.
Severe chronic non‑cancer pain: alleviates long‑term pain when alternative therapies are inadequate.

How It Works

Oxycodone Hydrochloride acts as a full agonist at the µ‑opioid receptors in the central nervous system. By binding to these G‑protein‑coupled receptors, it inhibits the release of nociceptive neurotransmitters, reduces neuronal excitability, and modifies pain perception pathways, resulting in analgesia.

Side Effects

Oxycodone Hydrochloride may cause a range of adverse reactions, from mild to life‑threatening.

Common Side Effects

Nausea
Constipation
Drowsiness
Dizziness
Dry mouth
Vomiting

Serious or Rare Side Effects

Respiratory depression
Severe hypotension
Seizures
Allergic reactions (rash, angioedema)
Dependence or addiction
Adrenal insufficiency

Precautions & Warnings

When prescribing Oxycodone Hydrochloride, clinicians should observe several safety measures.

Assess pain severity and treatment goals before initiating therapy.
Evaluate patient history for respiratory disorders such as COPD or sleep apnea.
Monitor for signs of dependence, tolerance, or misuse throughout treatment.
Avoid use in patients with severe hepatic impairment unless benefits outweigh risks.
Store at ambient temperature: keep in the original container, protect from moisture and heat.

Avoid Interactions

Oxycodone Hydrochloride interacts with several drug classes that may alter its safety or efficacy.

Major Interactions (Avoid)

Concomitant use with other opioids: increased risk of respiratory depression.
Benzodiazepines or other CNS depressants: synergistic sedation and respiratory effects.
Monoamine oxidase inhibitors (MAOIs): risk of severe hypertension or serotonin syndrome.

Moderate Interactions (Monitor Closely)

CYP3A4 inhibitors (e.g., erythromycin, ketoconazole): may raise oxycodone plasma concentrations.
CYP3A4 inducers (e.g., rifampin, carbamazepine): may reduce analgesic effect.
Anticholinergic agents: can exacerbate constipation.

Frequently Asked Questions

Oxycodone Hydrochloride Wockhardt Uk is an opioid analgesic indicated for the relief of moderate to severe pain, including acute postoperative pain, cancer‑related pain, and severe chronic non‑cancer pain when other treatments are insufficient.

Oxycodone hydrochloride binds to µ‑opioid receptors in the brain and spinal cord, activating inhibitory pathways that reduce the release of pain‑transmitting neurotransmitters, thereby decreasing the perception of pain.

The specific dose of oxycodone hydrochloride is determined by the prescribing clinician based on the patient’s pain severity, prior opioid exposure, age, renal and hepatic function, and other individual factors.

Oxycodone hydrochloride is classified as a Category C medication in pregnancy and is generally not recommended because it may cause neonatal withdrawal syndrome or respiratory depression. It is also excreted in breast milk, so breastfeeding is usually discouraged while using this drug.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements), and necessary import documentation.

Oxycodone is a strong µ‑opioid receptor agonist with a potency comparable to morphine but with a slightly faster onset of action. Compared with weaker opioids such as codeine, oxycodone provides more robust analgesia but also carries a higher risk of dependence and respiratory depression, requiring careful monitoring.

Oxycodone Hydrochloride tablets should be stored at ambient temperature, below 25 °C, in the original packaging to protect them from moisture, light, and excessive heat. Keep the product out of reach of children and unauthorized personnel.

The medication is supplied as oral tablets and is taken by mouth with or without food, as directed by the prescriber. Swallow the tablet whole; do not crush, chew, or split unless specifically instructed.

The most serious risks include respiratory depression, severe hypotension, profound sedation, dependence or addiction, and rare but life‑threatening allergic reactions. Patients should be monitored closely, especially during dose initiation or when combined with other CNS depressants.

Oxycodone should be avoided in individuals with known hypersensitivity to the drug, severe respiratory insufficiency, acute or severe asthma, paralytic ileus, or in patients who are actively being treated with MAO inhibitors. It is also contraindicated in patients with significant hepatic impairment unless the benefits outweigh the risks.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 10 Oct 2026

Disclaimer

International sale not permitted. Listed for the domestic market and B2B only.

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.